SCHEMBL22444732

SCHEMBL22444732

CNC(Cc1cncc(F)c1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.41
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
CYP2C9 P11712 1/20 0.38
NAMPT P43490 1/20 0.38
PPARG P37231 1/20 0.37
ACE P12821 1/20 0.36
GPR132 Q9UNW8 1/20 0.36
CTSB P07858 1/20 0.36
ALDH1A1 P00352 1/20 0.35
ITGB1 P05556 2/20 0.35
ITGA4 P13612 2/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
FDPS P14324 1/20 0.35
TBXAS1 P24557 2/20 0.34
AGTR2 P50052 1/20 0.34
KCNK3 O14649 2/20 0.34
CTSD P07339 1/20 0.34
BACE1 P56817 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31754334 1.00 HCAR2 (0.41) HCAR2CYP11B1CYP11B2CYP2C9NAMPT
SCHEMBL26008462 0.83 CTSB (0.49) HCAR2CYP11B1CYP11B2CYP2C9NAMPT
SCHEMBL13391884 0.82 ACE (0.40) PPARGACEALDH1A1
SCHEMBL21838030 0.82 PPARA (0.39) HCAR2CYP11B1CYP11B2CYP2C9NAMPT
SCHEMBL21838033 0.82 PPARA (0.39) HCAR2CYP11B1CYP11B2CYP2C9NAMPT
SCHEMBL25361477 0.82 HCAR2 (0.41) HCAR2ACEGPR132CTSBITGB1
SCHEMBL22444676 0.82 CASP3 (0.48) HCAR2ALDH1A1ITGA4
SCHEMBL22444674 0.82 HCAR2 (0.41) HCAR2ACEGPR132CTSBITGB1
SCHEMBL25358945 0.81 CYP11B1 (0.43) CYP11B1CYP11B2ACEGPR132ITGB1
SCHEMBL25358943 0.81 CYP11B1 (0.43) CYP11B1CYP11B2ACEGPR132ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240376044-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2024-11-14 US disclosed
US-12071396-B2 Method for preparing aromatic amino acid derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-08-27 US disclosed
US-20220144762-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2022-05-12 US disclosed
EP-3939962-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2022-01-19 EP disclosed
WO-2020189540-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE 中外製薬株式会社 2020-09-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240376044-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE DDC, AADAT, TYR HCAR2 923/4885CYP11B1 1294/4885CYP11B2 866/4885
US-20220144762-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE DDC, AADAT, TYR HCAR2 923/4885CYP11B1 1294/4885CYP11B2 866/4885
US-12071396-B2 Method for preparing aromatic amino acid derivative DDC, AADAT, TYR HCAR2 923/4885CYP11B1 1294/4885CYP11B2 866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.